High expression of ITGA2 is associated with poor prognosis in pancreatic cancer patients, and the mechanism involves the upregulation of PD-L1 and remodeling of the immune microenvironment [27]. This evidence concerns the gene ITGA2 and familial pancreatic carcinoma.